Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. A-Mark Precious Metals, Inc.
10.6% sales growth and 57.28% return on equity
A-Mark Precious Metals, Inc., together with its subsidiaries, operates as a precious metals trading company.
A-Mark Precious Metals, Inc. sales growth this year is anticipated to be 14.3% and a negative 9.6% for next year.
Year-on-year quarterly revenue growth grew by 26%, now sitting on 5.85B for the twelve trailing months.
A-Mark Precious Metals, Inc.'s sales growth is a negative 0% for the current quarter and 10.6% for the next. The company's growth estimates for the present quarter and the next is 505.9% and negative -51.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 57.28%.
A-Mark Precious Metals, Inc.'s stock is valued at $30.22 at 13:31 EST, way under its 52-week high of $37.60 and way higher than its 52-week low of $7.47.
A-Mark Precious Metals, Inc.'s worth is below its 50-day moving average of $32.46 and way higher than its 200-day moving average of $25.24.
2. First Horizon National Corporation
61% sales growth and 11.16% return on equity
First Horizon National Corporation operates as the bank holding company for First Horizon Bank that provides various financial services.
First Horizon National Corporation sales growth this year is anticipated to be 51.6% and 7.5% for next year.
Year-on-year quarterly revenue growth grew by 62.2%, now sitting on 1.94B for the twelve trailing months.
First Horizon National Corporation's sales growth for the next quarter is 61%. The company's growth estimates for the ongoing quarter and the next is a negative 29.8% and 560%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.16%.
First Horizon National Corporation's stock is valued at $12.28 at 13:31 EST, way below its 52-week high of $17.40 and way higher than its 52-week low of $6.27.
First Horizon National Corporation's worth is way above its 50-day moving average of $11.03 and way above its 200-day moving average of $9.88.
3. Tesla
60% sales growth and 5.59% return on equity
Tesla, Inc. designs, develops, manufactures, leases, and sells electric vehicles, and energy generation and storage systems in the United States, China, Netherlands, Norway, and internationally.
Tesla sales growth this year is anticipated to be 25.7% and 45.5% for next year.
Year-on-year quarterly revenue growth grew by 39.2%, now sitting on 28.18B for the twelve trailing months.
Tesla's sales growth for the next quarter is 60%. The company's growth estimates for the current quarter and the next is 112.2% and 265.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.59%.
Tesla's stock is valued at $585.76 at 13:31 EST, below its 52-week high of $598.78 and way above its 52-week low of $65.45.
Tesla's value is way higher than its 50-day moving average of $440.84 and way higher than its 200-day moving average of $333.87.
4. FIRST REPUBLIC BANK
12.7% sales growth and 9.77% return on equity
First Republic Bank, together with its subsidiaries, provides private banking, private business banking, real estate lending, and wealth management services to clients in metropolitan areas in the United States.
FIRST REPUBLIC BANK sales growth this year is anticipated to be 15.4% and 11.2% for next year.
Year-on-year quarterly revenue growth grew by 18.6%, now sitting on 3.58B for the twelve trailing months.
FIRST REPUBLIC BANK's sales growth for the next quarter is 12.7%. The company's growth estimates for the current quarter and the next is 8.6% and 17.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.77%.
FIRST REPUBLIC BANK's stock is valued at $130.73 at 13:31 EST, under its 52-week high of $142.14 and way above its 52-week low of $70.06.
FIRST REPUBLIC BANK's value is higher than its 50-day moving average of $127.90 and way above its 200-day moving average of $114.05.
5. Phoenix New Media Limited
30.9% sales growth and 28.4% return on equity
Phoenix New Media Limited provides content on an integrated Internet platform in the People's Republic of China.
Phoenix New Media Limited sales growth this year is anticipated to be 10.2% and 12% for next year.
Year-on-year quarterly revenue growth declined by 20.3%, now sitting on N/A for the twelve trailing months.
Phoenix New Media Limited's sales growth is a negative 0% for the ongoing quarter and 30.9% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 0% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.4%.
Phoenix New Media Limited's stock is valued at $2.27 at 13:31 EST, way under its 52-week high of $3.38 and way higher than its 52-week low of $1.15.
Phoenix New Media Limited's worth is way above its 50-day moving average of $1.47 and way above its 200-day moving average of $1.48.
Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
